Abstract

The linear ubiquitin chain assembly complex (LUBAC) is a ubiquitin ligase composed of the Heme-oxidized IRP2 ubiquitin ligase-1L (HOIL-1L), HOIL-1L-interacting protein (HOIP), and Shank-associated RH domain interactor (SHARPIN) subunits. LUBAC specifically generates the N-terminal Met1-linked linear ubiquitin chain and regulates acquired and innate immune responses, such as the canonical nuclear factor-κB (NF-κB) and interferon antiviral pathways. Deubiquitinating enzymes, OTULIN and CYLD, physiologically bind to HOIP and control its function by hydrolyzing the linear ubiquitin chain. Moreover, proteins containing linear ubiquitin-specific binding domains, such as NF-κB-essential modulator (NEMO), optineurin, A20-binding inhibitors of NF-κB (ABINs), and A20, modulate the functions of LUBAC, and the dysregulation of the LUBAC-mediated linear ubiquitination pathway induces cancer and inflammatory, autoimmune, and neurodegenerative diseases. Therefore, inhibitors of LUBAC would be valuable to facilitate investigations of the molecular and cellular bases for LUBAC-mediated linear ubiquitination and signal transduction, and for potential therapeutic purposes. We identified and characterized α,β-unsaturated carbonyl-containing chemicals, named HOIPINs (HOIP inhibitors), as LUBAC inhibitors. We summarize recent advances in elucidations of the pathophysiological functions of LUBAC-mediated linear ubiquitination and identifications of its regulators, toward the development of LUBAC inhibitors.

Highlights

  • Ubiquitin, a 76-residue (8.6 kDa) small globular protein, is evolutionally conserved in most eukaryotes

  • We further identified that mind bomb homolog 2 (MIB2) is an E3 that leads to the proteasomal degradation of CYLD, and MIB2 affects linear ubiquitin chain assembly complex (LUBAC)-mediated nuclear factor-κB (NF-κB) activation [108]

  • We hypothesized that the aggregable proteins in wisp inclusions may be initially conjugated with K48-linked ubiquitin chains; they seem to be resistant to the proteasomal degradation due to misfolding (Figure 6)

Read more

Summary

Introduction

A 76-residue (8.6 kDa) small globular protein, is evolutionally conserved in most eukaryotes. The K48-linked polyubiquitin chain, which is the most common, serves as a typical proteasomal degradation signal, and the K63-linked polyubiquitin chain, the second most predominant linkage, is involved in non-proteasomal functions, such as signal transduction and DNA repair [1,6] In addition to these Lys-linked polyubiquitin chains, the N-terminal Met1(M1)-linked linear polyubiquitination is generated by the E3 complex, named the linear ubiquitin chain assembly complex (LUBAC). Specific residues of ubiquitin are chemically modified, by phosphorylation, acetylation, and ADP-ribosylation, and these modifications regulate the pathophysiological functions of ubiquitination These diverse ubiquitin linkages exhibit multiple functions in a system called the “ubiquitin code” [6], in which E1, E2, and E3 function as “writers”, DUBs are “erasers”, and ubiquitin-binding proteins serve as “decoders”. We focus on the structures, catalytic mechanisms, inhibitors, and pathophysiological functions of the LUBAC-mediated “linear ubiquitin code”, revealed by studies using human cell lines, diseases, and phenotypes of genetically deficient mice

Structure and Catalytic Mechanism of LUBAC
LUBAC in the Genotoxic Stress Response and Inflammasome Activation
LUBAC-Mediated Regulation of Cell Death
LUBAC-Mediated Regulation of Interferon Signaling
Involvement of Linear Ubiquitination in Selective Autophagy
Erasers of the Linear Ubiquitin Code
Decoders of the Linear Ubiquitin Code
UBAN Domain-Containing Proteins
LUBAC-Related Disorders
Genetic Deficiency of LUBAC Subunits and Related Diseases
Enhanced LUBAC Expression and Cancers
Linear Ubiquitination in Neurodegenerative Diseases
HOIPINs
Findings
Conclusions and Perspectives

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.